Listen to RFI News
Expand Player
Listen Download Podcast
  • Paris Live PM 1300 - 1400 GMT
    News bulletin 05/24 13h00 GMT
  • Paris Live PM 1300 - 1400 GMT
    News bulletin 05/23 13h00 GMT
  • Paris Live PM 1300 - 1400 GMT
    News bulletin 05/22 13h00 GMT
  • 13h00 - 14h00 GMT
    News bulletin 04/05 13h00 GMT
  • 13h00 - 14h00 GMT
    News bulletin 04/04 13h00 GMT
  • 13h00 - 14h00 GMT
    News bulletin 04/03 13h00 GMT
To take full advantage of multimedia content, you must have the Flash plugin installed in your browser. To connect, you need to enable cookies in your browser settings. For an optimal navigation, the RFI site is compatible with the following browsers: Internet Explorer 8 and above, Firefox 10 and +, Safari 3+, Chrome 17 and + etc.
Latest news
  • At least eight wounded in Lyon in suspected parcel bomb attack (Interior Ministry)

Apology to Thalidomide victims 50 years later

media Thalidomide caused nearly 10000 birth defects. AFP PHOTO/Heckmann

Victims of the drug thalidomide, have finally received an apology 50 years later from German drug company Grunenthal on Friday.

Harald Stock, the executive director of Grunenthal, said the company was “truly sorry” for its nearly years of silence.

Towards the end of the 1950s and early 60s, it was the drug of choice for pregnant women suffering from morning sickness. The drug was touted as a ‘marvelous sedative’ in 1956, and its biggest buyers were Japan, Canada and Germany. In total, nearly 46 countries had approved Thalidomide.

However, it had devastating and irreversible effects on the fetus. Nearly 10,000 to 20,000 people were born missing segments of their legs or arms, because their mothers were prescribed thalidomide.

France was one of the few countries that allowed its sale for a short time, just towards the end of December 1961. However it was strictly controlled and was soon pulled off the market after its effects were questioned.

France is one of the few countries that has very little, if any victims from the anti-nausea drug.

Sales of thalidomide were eventually stopped in 1962.

Today, thalidomide is being studied for its effectiveness in treating autoimmune diseases, such as leprosy, lupus erythematosus, and a rare form of bone marrow cancer. It is also used in treating inflammatory diseases such as Crohn’s.

Sorry but the period of time connection to the operation is exceeded.